NCT02641171 Volatiles in Exhaled Breath and Blood in Crohn's Disease: Validation Cohort Status TERMINATED Phase N/A
NCT02630966 Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease Status COMPLETED Phase PHASE4
NCT02624414 Capsule Colonoscopy in Crohn's Disease and Its Correlation With Conventional Colonoscopy and Faecal Calprotectin Status COMPLETED Phase NA
NCT02622763 Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment Status TERMINATED Phase PHASE1
NCT02622139 Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD) Status COMPLETED Phase NA
NCT02620514 Medication Adherence in Patients With Inflammatory Bowel Disease (IBD) Status COMPLETED Phase NA
NCT02620046 A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease Status COMPLETED Phase PHASE3
NCT02619552 Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease Status COMPLETED Phase N/A
NCT02611817 Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD) Status COMPLETED Phase PHASE3
NCT02597829 Does Clinical Response Correlate With Serum Certolizumab Levels? Status UNKNOWN Phase PHASE4
NCT02580617 A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease Status UNKNOWN Phase PHASE1
NCT02578576 The Diagnostic Methods of Early Postoperative Flare-up of Crohn's Disease Status UNKNOWN Phase N/A
NCT02574637 Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease Status TERMINATED Phase PHASE2
NCT02559713 Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease Status COMPLETED Phase PHASE4
NCT02550158 A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease Status COMPLETED Phase NA